Health
AI Drug Firm Recursion Wants to Be Amazon Prime of Pharma
This article is for subscribers only.
AI drug developer Recursion Pharmaceuticals Inc. is considering an Amazon Prime-style subscription model for selling its pipeline of medicines.
The Salt Lake City-based biotech wants to create a system where a US employer could pay, for example, $45 a month per employee to access any medicine Recursion develops regardless of price — provided it’s prescribed by a doctor. If successful, the move has the potential to revolutionize how drugs are sold.